111, Inc. (NASDAQ:YI) Short Interest Update

111, Inc. (NASDAQ:YI) saw a significant growth in short interest during the month of January. As of January 31st, there was short interest totalling 23,700 shares, a growth of 66.9% from the January 15th total of 14,200 shares. Based on an average daily trading volume, of 31,600 shares, the days-to-cover ratio is presently 0.8 days. Approximately 0.5% of the shares of the company are short sold.

111 Price Performance

Shares of YI opened at $7.36 on Thursday. The company has a market capitalization of $62.93 million, a price-to-earnings ratio of -1.84 and a beta of 0.41. The business’s 50-day moving average is $6.42 and its 200-day moving average is $7.56. 111 has a fifty-two week low of $4.14 and a fifty-two week high of $15.80.

111 (NASDAQ:YI) last released its quarterly earnings data on Wednesday, November 27th. The company reported ($0.20) EPS for the quarter.

Institutional Trading of 111

A hedge fund recently bought a new stake in 111 stock. Napean Trading & Investment Co Singapore PTE Ltd bought a new position in shares of 111, Inc. (NASDAQ:YI) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 393,161 shares of the company’s stock, valued at approximately $245,000. Napean Trading & Investment Co Singapore PTE Ltd owned 4.60% of 111 at the end of the most recent reporting period. Institutional investors own 21.32% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of 111 in a research report on Saturday, February 1st.

About 111

111, Inc engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies.